Literature DB >> 31473800

Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics.

Markus Wenzel1, Fausto Milletari2,3, Julia Krüger4, Catharina Lange5, Michael Schenk6, Ivayla Apostolova6, Susanne Klutmann6, Marcus Ehrenburg7, Ralph Buchert8.   

Abstract

PURPOSE: This study investigated the potential of deep convolutional neural networks (CNN) for automatic classification of FP-CIT SPECT in multi-site or multi-camera settings with variable image characteristics.
METHODS: The study included FP-CIT SPECT of 645 subjects from the Parkinson's Progression Marker Initiative (PPMI), 207 healthy controls, and 438 Parkinson's disease patients. SPECT images were smoothed with an isotropic 18-mm Gaussian kernel resulting in 3 different PPMI settings: (i) original (unsmoothed), (ii) smoothed, and (iii) mixed setting comprising all original and all smoothed images. A deep CNN with 2,872,642 parameters was trained, validated, and tested separately for each setting using 10 random splits with 60/20/20% allocation to training/validation/test sample. The putaminal specific binding ratio (SBR) was computed using a standard anatomical ROI predefined in MNI space (AAL atlas) or using the hottest voxels (HV) analysis. Both SBR measures were trained (ROC analysis, Youden criterion) using the same random splits as for the CNN. CNN and SBR trained in the mixed PPMI setting were also tested in an independent sample from clinical routine patient care (149 with non-neurodegenerative and 149 with neurodegenerative parkinsonian syndrome).
RESULTS: Both SBR measures performed worse in the mixed PPMI setting compared to the pure PPMI settings (e.g., AAL-SBR accuracy = 0.900 ± 0.029 in the mixed setting versus 0.957 ± 0.017 and 0.952 ± 0.015 in original and smoothed setting, both p < 0.01). In contrast, the CNN showed similar accuracy in all PPMI settings (0.967 ± 0.018, 0.972 ± 0.014, and 0.955 ± 0.009 in mixed, original, and smoothed setting). Similar results were obtained in the clinical sample. After training in the mixed PPMI setting, only the CNN provided acceptable performance in the clinical sample.
CONCLUSIONS: These findings provide proof of concept that a deep CNN can be trained to be robust with respect to variable site-, camera-, or scan-specific image characteristics without a large loss of diagnostic accuracy compared with mono-site/mono-camera settings. We hypothesize that a single CNN can be used to support the interpretation of FP-CIT SPECT at many different sites using different acquisition hardware and/or reconstruction software with only minor harmonization of acquisition and reconstruction protocols.

Entities:  

Keywords:  Convolutional neural network; Deep learning; Domain adaption; Dopamine transporter; FP-CIT; SPECT

Year:  2019        PMID: 31473800     DOI: 10.1007/s00259-019-04502-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  52 in total

1.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

Review 2.  Quantitative approaches to dopaminergic brain imaging.

Authors:  K Tatsch; G Poepperl
Journal:  Q J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 2.346

Review 3.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

Review 4.  A survey on deep learning in medical image analysis.

Authors:  Geert Litjens; Thijs Kooi; Babak Ehteshami Bejnordi; Arnaud Arindra Adiyoso Setio; Francesco Ciompi; Mohsen Ghafoorian; Jeroen A W M van der Laak; Bram van Ginneken; Clara I Sánchez
Journal:  Med Image Anal       Date:  2017-07-26       Impact factor: 8.545

5.  Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson's disease based on [123I]FP-CIT SPECT images.

Authors:  Francisco P M Oliveira; Diogo Borges Faria; Durval C Costa; Miguel Castelo-Branco; João Manuel R S Tavares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-23       Impact factor: 9.236

6.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.

Authors:  J Booij; J D Speelman; M W Horstink; E C Wolters
Journal:  Eur J Nucl Med       Date:  2001-03

7.  Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.

Authors:  Philipp T Meyer; Bernhard Sattler; Thomas Lincke; Anita Seese; Osama Sabri
Journal:  J Nucl Med       Date:  2003-05       Impact factor: 10.057

Review 8.  Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update.

Authors:  Klaus Tatsch; Gabriele Poepperl
Journal:  J Nucl Med       Date:  2013-07-17       Impact factor: 10.057

9.  The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging.

Authors:  John C Dickson; Livia Tossici-Bolt; Terez Sera; Jan Booij; Morten Ziebell; Silvia Morbelli; Susanne Assenbaum-Nan; Thierry Vander Borght; Marco Pagani; Ozlem L Kapucu; Swen Hesse; Koen Van Laere; Jacques Darcourt; Andrea Varrone; Klaus Tatsch
Journal:  EJNMMI Res       Date:  2017-01-24       Impact factor: 3.138

10.  Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.

Authors:  John T O'Brien; Wolfgang H Oertel; Ian G McKeith; Donald G Grosset; Zuzana Walker; Klaus Tatsch; Eduardo Tolosa; Paul F Sherwin; Igor D Grachev
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692

View more
  9 in total

1.  Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson's disease.

Authors:  Takuro Shiiba; Kazuki Takano; Akihiro Takaki; Shugo Suwazono
Journal:  EJNMMI Res       Date:  2022-06-27       Impact factor: 3.434

2.  Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning.

Authors:  Yu Zhao; Jianjun Wu; Ping Wu; Matthias Brendel; Jiaying Lu; Jingjie Ge; Chunmeng Tang; Jimin Hong; Qian Xu; Fengtao Liu; Yimin Sun; Zizhao Ju; Huamei Lin; Yihui Guan; Claudio Bassetti; Markus Schwaiger; Sung-Cheng Huang; Axel Rominger; Jian Wang; Chuantao Zuo; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-19       Impact factor: 10.057

3.  Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges.

Authors:  Shichun Peng; Phoebe G Spetsieris; David Eidelberg; Yilong Ma
Journal:  Ann Transl Med       Date:  2020-07

4.  Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT.

Authors:  Helen Schmitz-Steinkrüger; Catharina Lange; Ivayla Apostolova; Holger Amthauer; Wencke Lehnert; Susanne Klutmann; Ralph Buchert
Journal:  EJNMMI Phys       Date:  2020-05-20

5.  Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI.

Authors:  Mahmood Nazari; Andreas Kluge; Ivayla Apostolova; Susanne Klutmann; Sharok Kimiaei; Michael Schroeder; Ralph Buchert
Journal:  Sci Rep       Date:  2021-11-25       Impact factor: 4.379

6.  Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes.

Authors:  Mahmood Nazari; Andreas Kluge; Ivayla Apostolova; Susanne Klutmann; Sharok Kimiaei; Michael Schroeder; Ralph Buchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-15       Impact factor: 9.236

7.  Soft Attention Based DenseNet Model for Parkinson's Disease Classification Using SPECT Images.

Authors:  Mahima Thakur; Harisudha Kuresan; Samiappan Dhanalakshmi; Khin Wee Lai; Xiang Wu
Journal:  Front Aging Neurosci       Date:  2022-07-13       Impact factor: 5.702

8.  Multiple-pinhole collimators improve intra- and between-rater agreement and the certainty of the visual interpretation in dopamine transporter SPECT.

Authors:  Franziska Mathies; Ivayla Apostolova; Lena Dierck; Janin Jacobi; Katja Kuen; Markus Sauer; Michael Schenk; Susanne Klutmann; Attila Forgács; Ralph Buchert
Journal:  EJNMMI Res       Date:  2022-08-17       Impact factor: 3.434

Review 9.  Imperative Role of Machine Learning Algorithm for Detection of Parkinson's Disease: Review, Challenges and Recommendations.

Authors:  Arti Rana; Ankur Dumka; Rajesh Singh; Manoj Kumar Panda; Neeraj Priyadarshi; Bhekisipho Twala
Journal:  Diagnostics (Basel)       Date:  2022-08-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.